Apollon Wealth Management, LLC - CHECKPOINT THERAPEUTICS INC ownership

CHECKPOINT THERAPEUTICS INC's ticker is and the CUSIP is 162828206. A total of 39 filers reported holding CHECKPOINT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
Apollon Wealth Management, LLC ownership history of CHECKPOINT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$23,630
-78.5%
13,900
-68.7%
0.00%
-80.0%
Q2 2023$109,740
+41.9%
44,429
+29.2%
0.01%0.0%
Q1 2023$77,353
-42.6%
34,379
+30.4%
0.01%
-50.0%
Q4 2022$134,68926,3580.01%
Other shareholders
CHECKPOINT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 54,983$280,9631.24%
TWINBEECH CAPITAL LP 113,152$14,275,2560.27%
Telemetry Investments, L.L.C. 10,000$510.08%
ARMISTICE CAPITAL, LLC 691,895$3,535,5830.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 12,564$64,2020.04%
EMFO, LLC 7,795$39,8320.04%
Apollon Wealth Management, LLC 26,358$134,6890.01%
PARK AVENUE SECURITIES LLC 46,545$238,0000.00%
B. Riley Wealth Advisors, Inc. 19,150$97,8570.00%
Tower Research Capital LLC (TRC) 9,548$490.00%
View complete list of CHECKPOINT THERAPEUTICS INC shareholders